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Background: The prevalence of chronic kidney disease (CKD) is rising worldwide. The global population of 
end-stage renal disease (ESRD) patients continues to grow at a rate of 7% per annum. Community-based 
prevalence rates are not available in India. At the time of presentation to physicians, most CKD patients already 
have ESRD. Progression of the disease is slow initially, but becomes exponential in the later phases. The time 
period before ESRD is reached is an opportunity to retard disease progression, but it is generally not exploited.
For early diagnosis and involvement of nephrologists in the early stages of CKD, the role of physicians is 
crucial. Here, we studied physicians’ views on CKD and related issues. 
Methods: A cross-sectional, self-administered, questionnaire-based survey of 104 physicians working in Delhi 
was carried out between March and July 2004. The respondents were trained in internal medicine. Nephrologists 
and physicians working in nephrology units were excluded. The questionnaire consisted of 14 open-ended 
questions under the following subheadings: magnitude of the problem, treatment facilities, treatment costs, 
constraints, markers, and referrals. 
Results: Physicians’ information on the magnitude of the problem was vague, but they felt that CKD would 
assume public health significance. Renal replacement therapy was the preferred mode of treatment, although 
its cost was considered to be unaffordable by most patients. About 41% of respondents identified glomerular 
filtration rate (GFR) as the ideal marker, while 38% of respondents identified serum creatinine level as the 
ideal marker, ignoring its limitations. 
Conclusion: Respondents recognized the impending epidemic of CKD; however, their knowledge on the natural 
history of the disease, markers and therapies was inadequate and needs strengthening. Serum creatinine is a 
good screening test, but has limitations. GFR is the preferred measure, but also involves considerable effort
and time, and is costly. In view of these, in settings with limited resources such as India, efforts should be made 
to use the available nomograms and mathematical formulae to predict GFR based on serum creatinine. Whenever
serum creatinine measurements are requested, the routine report should also include the derived GFR, which 
would help in the early diagnosis of CKD. [Hong Kong J Nephrol 2006;8(2):55–60] 
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INTRODUCTION
The prevalence of chronic kidney disease (CKD) is
rising worldwide. The global population of end-stage
renal disease (ESRD) patients continues to grow at a
rate of 7% per annum due to demographic transition,
increase in diseases leading to CKD, and increased
availability of diagnostic and therapeutic facilities.
Community-based prevalence rates are not available
in India. However, it is estimated that approximately
100,000 new patients develop ESRD in India annually
[1]. At the time of presentation to physicians, most
CKD patients already have ESRD (glomerular
filtration rate [GFR] < 10 mL/min). Very few patients
present at the earlier stages of chronic renal
insufficiency (GFR between 30 and 70 mL/min),
which is the preferred term for mild to moderate renal
impairment, and chronic renal failure (CRF; GFR
between 10 and 30 mL/min). The various stages of
the disease represent a continuum [2].
The US National  Kidney Foundation has
proposed a staging system for CKD to promote
uniformity in nomenclature and to provide a common
language of communication [3]. The Kidney Disease
Outcome Quality Initiative advisory board suggested
that the term chronic kidney disease should be used
in place of chronic renal failure. However, in this
survey, both these terms were used interchangeably.
This is because the respondents did not make any
distinction between these two terms, as found in a
review of the responses before the questionnaire was
finalized.
Progression of the disease is slow initially, but
becomes exponential in the later phases. The time
period before ESRD is reached is an opportunity to
retard disease progression, but it is not being exploited.
For early diagnosis and involvement of nephrologists
in the early stages of CKD, the role of physicians is
crucial. Hence, we studied physicians’ views on CKD
and related issues, as it may be helpful in the planning
of appropriate strategies to control the impending
epidemic of CKD.
METHODS
A cross-sectional, self-administered, questionnaire-
based survey of physicians working in different tertiary
care centers in the city of Delhi was carried out between
March and July 2004. The centers included teaching
and non-teaching institutions, belonging to public and
private sectors. All the respondents were trained in
internal medicine. Nephrologists and physicians
working in nephrology units were excluded. The
questionnaire consisted of 14 open-ended questions
under the subheadings of magnitude of the problem,
treatment facilities, treatment costs, constraints,
markers, and referrals (Appendix). Open-ended
questions were phrased deliberately to avoid giving any
suggestions to the respondents, which may bias the
responses. The questionnaires were circulated among
the prospective respondents with a request to return after
answering all questions. Respondents were instructed
to respond briefly to each question; they were allowed
to give figures or answer descriptively, as applicable to
each item.
After receiving the questionnaires back from the
respondents, they were all reviewed for completeness.
Although individual questions were open-ended
without any suggestions or prompts for responses, the
answers fell into natural categories. For example,
responses to the item on available modalities of therapy
for CRF were dialysis, renal transplant, conservative and
other. On the magnitude of the problem, both in clinical
practice and in the community, when guessed figures
were quoted, a prevalence of 1% or more was taken as
common and below 1% as uncommon. Clear-cut
responses as common or uncommon were taken as such.
RESULTS
A total of 125 questionnaires were circulated, of which
104 were received back and confirmed to be completed,
giving a response rate of 83.2%. A summary of the
physicians’ responses are shown in the Table.
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Magnitude of CKD
Most of the respondents (90%) felt that CKD was
common in clinical practice, whereas only 60% felt that
it was common in the community. The majority of
respondents (89%) felt that CKD was beginning to
Table. Physicians’ responses to the questionnaire on chronic kidney disease
A. Magnitude of the problem
1. Prevalence in clinical practice
Common: 90.4%
Uncommon: 9.6%
2. Prevalence in community
Common: 60.6%
Uncommon: 28.9%
NK: 10.5%
3. Public health significance
Yes: 89.4%
No: 8.7%
NK: 1.9%
4. Remedial measures to control the epidemic
General comments: 33.7%
Treatment of comorbidities: 26.9%
Early diagnosis: 21.1%
Physician education: 4.8%
No measures suggested: 13.5%
B. Treatment facilities
5. Modalities of therapy
Dialysis + transplantation: 54.8%
Conservative + dialysis + transplantation: 25.0%
Dialysis: 15.4%
Conservative + dialysis: 1.9%
Nonspecific/unrelated: 2.9%
6. Adequacy of available services
Public sector
Inadequate: 94.2%
Adequate: 5.8%
Private sector
Inadequate: 84.6%
Adequate: 15.4%
C. Treatment costs
7. Affordability of treatment costs
No: 90.4%
Yes: 7.7%
NK: 1.9%
8. Suitable mode of treatment from the angle of costs
Dialysis: 49.0%
Transplantation: 11.5%
Dialysis + transplantation: 4.8%
Conservative: 12.5%
Conservative + other: 10.7%
NK: 11.5%
D. Constraints
9. Constraints in the most suitable therapy suggested
Non-availability of services: 26.0%
Costs: 23.1%
Non-availability + costs: 23.1%
Delayed diagnosis: 2.9%
None: 6.7%
Other: 18.2%
10. Measures to reduce the constraints for the suggested therapy
Make services available: 26.0%
Reduce costs: 9.6%
Make services available + reduce costs: 6.7%
Early diagnosis: 1.0%
No measures suggested: 56.7%
E. Markers
11. Best markers
Diagnosis
GFR: 40.4%
SCr: 38.5%
Other: 21.1%
Monitoring
GFR: 41.3%
SCr: 38.5%
Others: 20.2%
F. Referral
12. Stage at which patients are seen by physicians
ESRD needing dialysis/transplantation: 53.8%
Staging based on GFR: 4.8%
Staging based on SCr: 1.9%
Late/advanced stage: 17.3%
Early stage: 3.9%
Not clear: 18.3%
13. Stage at which patients are referred to nephrologists by physicians
ESRD needing dialysis/transplantation: 28.8%
Staging based on GFR: 3.8%
Staging based on SCr: 4.8%
Late/advanced stage: 5.8%
Early stage (as soon as physician sees patient): 38.5%
Not clear: 18.3%
14. Stage at which a nephrologist should be involved
ESRD needing dialysis/transplantation: 17.3%
Staging based on GFR: 8.7%
Staging based on SCr: 3.9%
Late/advanced stage: 1.0%
Early stage: 63.4%
Not clear: 5.7%
NK = not known; GFR = glomerular filtration rate; SCr = serum creatinine; ESRD = end-stage renal disease.
assume or would likely assume public health signi-
ficance. Regarding remedial measures to control the
CKD epidemic, most were unaware (13.5%) or offered
only general, nonspecific health measures (33.7%). On
the other hand, 27% felt that treatment of comorbid
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conditions might control the CKD epidemic. Only 21%
proposed that early diagnosis should be attempted to
control the epidemic of CKD, indirectly indicating
conservative management as a measure to control the rise
of CKD. Only 4.8% of respondents proposed physician
education as a key point in improving the situation.
Treatment facilities
Regarding the available modalities of therapy, renal
replacement therapy (RRT) in one form or another was
identified as a suitable mode of therapy. Conservative
management alone was not identified as a mode of therapy
or the answer to the control of the CKD epidemic, but as
a possibly useful addition to RRT. The available services
for the treatment of CKD were felt to be inadequate in
both the public (94.2%) and private (84.6%) sectors.
Costs and constraints
The majority of respondents (90%) felt that the costs
of treatment were unaffordable. However, despite this
recognition, up to 70% of respondents indicated
that RRT in some form was their treatment of choice.
Only 12.5% of respondents felt that conservative
management alone was suitable for the Indian setup;
11.5% were not sure of anything.
Non-availability of services and costs were felt to be
the major constraints in controlling the CKD epidemic.
Difficulties in diagnosing CKD early and other
procedural, technical difficulties were not considered to
be constraints; 18.2% of respondents were not sure of
anything and 6.7% felt that there were no constraints at all.
Measures to reduce the constraints in the suitable
mode of therapy were mostly related to reduction of
costs and increasing the availability of services, as
indicated by the respondents. More than half of the
respondents (56.7%) did not suggest any measures.
Markers for diagnosis and monitoring
About 41% of respondents indicated that GFR was the
best marker for CKD diagnosis and monitoring.
Similarly, 38.5% indicated that serum creatinine was
the best marker for both diagnosis and monitoring of
CKD, ignoring its limitations [4,5]. About 20% were
not sure or clear and indicated various other markers
as the best ones for diagnosis and monitoring. There
was remarkable symmetry in the identification of
markers for both diagnosis and monitoring.
Referrals
Although the majority of respondents (63.4%) felt that
they should ideally refer patients to a nephrologist in
the early stage of the disease, less than 10% actually
did so. Among those who did refer early, 38.5% referred
their patients to a nephrologist as soon as they saw them.
However, as patients presented to physicians with late-
stage CKD, invariably, the physicians referred late.
DISCUSSION
Most of the physicians (90%) recognized that CKD was
common in clinical practice, but fewer (60%) felt that
it was common in the community. Some (28.9%) even
thought that CKD was uncommon in the community.
Most (89.4%) believed that it was assuming public
health significance. Although the majority recognized
the magnitude of the problem both in clinical practice
and in the community, only 21.1% of them appreciated
the importance of early diagnosis. About one third of
respondents made only general comments on
improvement of health and 13.5% did not suggest any
measures to control the impending CKD epidemic.
The importance of physician education was also not
realized.
When the magnitude of the problem in clinical
practice is high, logically, there should be a cor-
responding high prevalence of patients in the earlier
stages of CKD in the community. However, the
physician responses observed were not in consonance
with this logic. This may be an indication of an in-
adequate comprehension of the natural history of the
disease on the part of the physicians.
Despite the recognition by most respondents that
treatment costs were unaffordable and treatment
facilities were inadequate, both in the public and
private sectors, only one in eight physicians felt that
conservative management alone was suitable for the
Indian setup. At best, conservative management was
considered to be useful in addition to RRT, which was
the preferred mode of treatment for CKD as suggested
by 70% of the physicians.
Most physicians felt that the costs and the lack of
facilities were the major constraints for their preferred
mode of treatment i.e. RRT. Delayed diagnosis was a
constraint for a few respondents (2.9%). More than half
(56.7%) did not suggest any measures to overcome the
constraints for their preferred mode of treatment. The
remaining suggested that the costs need to be reduced
and that treatment facilities must be made easily
available.
Regarding markers for diagnosis and monitoring of
CKD, about 41% considered GFR to be the best marker.
An almost equal number (38.5%) indicated serum
creatinine to be the best marker, ignoring its limitations.
About one fifth suggested various other less important
and unreliable measures to be the best markers.
Serum creatinine is a good marker for the diagnosis
and monitoring of CKD, but has some limitations
[5,6]. GFR is the preferred measure, but involves
considerable effort, time, and costs. In practice, it may
not be feasible to measure it routinely. In view of this,
for a country such as India, efforts to measure GFR
indirectly through available nomograms and
mathematical formulae based on serum creatinine
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should be utilized [6] because serum creatinine can be
easily measured. Therefore, the routine report should
also include the derived GFR, which can help in the
early diagnosis and better monitoring of CKD.
Regarding referrals, 63.4% of respondents felt that
they should refer CKD patients to nephrologists early,
but less than 10% actually did so. Even those physicians
who referred early could only refer as early as possible,
meaning that in practice, patients were referred to
nephrologists when they were already in the advanced
stages of the disease as the physicians were getting their
patients in the advanced stages of CKD only. These
results indicate that there is a delay at every level.
Awareness in both the general public and in physicians
might improve this state of affairs.
The present survey did not select respondents by a
strictly random procedure. Ideally, the study should
have required a sampling frame of all the physicians
working in Delhi and a random sample be chosen from
it. But since this was not feasible, physicians working
in various city hospitals were surveyed. The studied
sample of physicians from tertiary care centers was
expected to represent the total number of physicians in
Delhi. To that extent, the generalizability of the results
may be limited. A larger study with a random selection
of physicians with various levels of experience might
give more generalizable results. It should also be
emphasized that our selection of respondents was from
major tertiary care institutes only; in view of this, our
results could have overestimated the knowledge of the
CKD problem among physicians. The knowledge of
physicians who are not affiliated to any major institute
is generally expected to be lower than that of physicians
who are affiliated to a major institute. In that sense, we
may be conservative in our conclusion regarding the
inadequate comprehension of CKD and related issues
among physicians in Delhi.
To summarize, most physicians recognized the
impending epidemic of CKD. However, their
knowledge on the natural history of the disease, markers
for diagnosis and monitoring, and appropriate therapies
needs strengthening. Patients with early CKD can be
diagnosed through laboratory tests only, and this fact
must be recognized and practiced. There is a need to
develop practice guidelines for the diagnosis, treatment
and referral of CKD patients, and adherence to the
guidelines should be enforced. Routine use of GFR or
derived GFR to diagnose CKD early, followed by
conservative management, could be the major
component of such guidelines, which might help to
solve most of the problems associated with this
epidemic. Conservative management may include:
dietary management with low salt and low protein
intake; effective glycemic and blood pressure control
with angiotensin converting enzyme inhibitors or
angiotensin receptor blockers or both; additional
antihypertensive agents if required; control of anemia
with oral iron supplementation, and folic acid along
with erythropoietin; use of phosphate binders, vitamin
D3 or calcium supplementation; symptomatic
treatment. A consistent public health approach needs
to be developed to control the impending epidemic of
CKD, and a concerted effort needs to be made to
implement it properly all over the country to curtail
the attendant costs and suffering of patients and
their families.
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Appendix
A. Magnitude of the problem (you may give figures or answer descriptively)
1. In your opinion, how common is CRF/CKD in clinical practice?
2. In your opinion, how common is CRF/CKD in the community in general?
3. In your opinion, is the magnitude of CRF/CKD assuming or likely to assume public health significance?
4. If YES to Q3, what remedial measures would you propose?
B. Treatment facilities
5. What are the various modalities of therapy or services available for CRF/CKD?
6. In your opinion, are available services adequate as per the needs or requirements in the
- public sector?
- private sector?
C. Treatment costs
7. Are treatment costs affordable?
8. From the angle of costs, what is the most suitable modality of therapy for our set-up?
D. Constraints
9. Are there any constraints to the above-mentioned (most suitable) modality of therapy?
10. If YES to Q9, what measures would you propose to be adopted for reducing the constraints?
E. Markers
11. In your opinion, what is the best indicator/marker for the
- diagnosis of CRF/CKD?
- monitoring of CRF/CKD?
F. Referral
12. Usually, when (at what stage) do you see your CRF/CKD patients?
13. When (at what stage) do you refer a CRF/CKD patient to a nephrologist?
14. When (at what stage) do you think a nephrologist should best be involved?
Questionnaire on Chronic Renal Failure (CRF) / Chronic Kidney Disease (CKD)
Please answer the following questions briefly.
Demographic profile of respondent
Name (optional): Age: Gender:
Qualification: MD / DNB / PG Diploma Subject:
Super specialty (DM): Subject:
Work set-up: Practitioner / Teaching institute / Non-teaching general hospital
